Latest bone marrow transplant Stories

New Drug Reduces Risk Of Deadly Transplant Side Effect

2012-12-10 16:43:16

First study in humans shows promise for preventing graft-versus-host disease following bone marrow transplant A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments, according to a study from researchers at the University of Michigan Comprehensive Cancer Center. The study, the first to test this treatment in people, combined the drug vorinostat with standard medications given after transplant,...

Enlivex Therapeutics Announces Positive Results in Completion of Clinical Trial for the Treatment of Bone Marrow Transplant Recipients

2012-10-24 07:32:14

JERUSALEM, Oct. 24, 2012 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that its portfolio company Enlivex has completed a clinical trial and is reporting positive results that indicate efficacy and safety in its treatment for recipients of bone marrow transplants from...

Christiana Care Health System Achieves Accreditation by FACT

2012-04-10 02:27:37

WILMINGTON, Del., April 10, 2012 /PRNewswire-USNewswire/ -- Christiana Care Health System's Bone Marrow Transplant Program was recently awarded accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT). (Logo: http://photos.prnewswire.com/prnh/20090407/DC95299LOGO) FACT establishes standards for high quality medical and laboratory practice in cellular therapies and is headquartered at the University of Nebraska Medical Center in Omaha. FACT is a non-profit...

Bone Marrow Transplant Arrests Symptoms Un Model Of Rett Syndrome

2012-03-19 10:10:51

Results emphasize immune component of autism spectrum disorder A paper published online today in Nature describes the results of using bone marrow transplant (BMT) to replace faulty immune system cells in models of Rett Syndrome. The procedure arrested many severe symptoms of the childhood disorder, including abnormal breathing and movement, and significantly extended the lifespan of Rett mouse models. Exploring the function of microglia deficient in methyl-CpG binding protein 2 (Mecp2),...

Bone Marrow Transplant Arrests Symptoms in Model of Rett Syndrome

2012-03-19 02:23:14

Results Emphasize Immune Component of Autism Spectrum Disorder TRUMBULL, Conn., March 19, 2012 /PRNewswire-USNewswire/ -- A paper published online in Nature describes the results of using bone marrow transplant (BMT) to replace faulty immune system cells in models of Rett Syndrome. The procedure arrested many severe symptoms of the childhood disorder, including abnormal breathing and movement, and significantly extended the lifespan of Rett mouse models. Exploring the function of...

Combination Treatment In Mice Shows Promise For Fatal Neurological Disorder In Kids

2012-03-16 11:10:09

Infants with Batten disease, a rare but fatal neurological disorder, appear healthy at birth. But within a few short years, the illness takes a heavy toll, leaving children blind, speechless and paralyzed. Most die by age 5. There are no effective treatments for the disease, which can also strike older children. And several therapeutic approaches, evaluated in mouse models and in young children, have produced disappointing results. But now, working in mice with the infantile form of...

Virginia G. Piper Cancer Center Opens Cancer Transplant Institute

2012-02-24 09:00:00

New hematopoietic stem cell transplant program in Scottsdale, Ariz. offers treatment for blood cancers SCOTTSDALE, Ariz., Feb. 24, 2012 /PRNewswire-USNewswire/ -- The Virginia G. Piper Cancer Center at Scottsdale Healthcare announced today it has added a hematopoietic stem cell (HSC) transplant cancer treatment program (a/k/a bone marrow transplant) through its new Cancer Transplant Institute. Leaders of the new cancer treatment program expect it to attract transplant patients...

Velos, Inc. Unveils Free iPad Apps for Oncology Adverse Event Management and Graft-versus-host Disease Tracking

2012-02-01 13:24:00

FREMONT, Calif., Feb. 1, 2012 /PRNewswire/ -- Velos, Inc., a healthcare technology company, will unveil its Velos Aversi and Velos Aversi GVHD iPad apps at the 2012 Bone Marrow Transplant (BMT) Tandem Meetings in San Diego, California, February 1-4, 2012. Velos Aversi is designed to enhance point-of-care recording and tracking of adverse events based on the Common Terminology Criteria for Adverse Events (CTCAE). Velos Aversi GVHD enables clinicians to assess, track, and review...

New Half-Match Bone Marrow Transplant Procedure Yields Promising Outcomes For Cancer Patients

2011-09-02 11:20:55

Kimmel Cancer Center at Jefferson clinical trial found improved overall survival in blood cancer patients who received two-step, half-match bone marrow transplant procedure Half-matched bone marrow or stem cell transplants for blood cancer patients have typically been associated with disappointing clinical outcomes. However, a clinical trial conducted at the Kimmel Cancer Center at Jefferson testing its unique, two-step half-match procedure has produced some promising results: the...

Can a Legal Thriller Do More Than Thrill?

2011-04-13 23:00:00

'Novel' Reality Program Aims to Boost Breast Cancer, Leukemia Awareness ... and Recruit New Bone Marrow Donors NEW YORK, April 14, 2011 /PRNewswire-USNewswire/ -- The arsenal of tools to educate the public about the constant need for bone marrow donors - websites, social media, patient testimonials, fundraising events, television public service announcements - is welcoming a new partner: a reality-based legal thriller in which one of the major characters gets sick. "The Matriarchs," a novel...